Hinge Health Inc (NYSE:HNGE) price on Wednesday, July 02, fall -1.54% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $44.61.
A look at the stock’s price movement, the close in the last trading session was $45.31. The PE ratio in trailing twelve months stood at 10.95. Turning to its 52-week performance, $52.16 and $33.42 were the 52-week high and 52-week low respectively. Overall, HNGE moved 10.28% over the past month.
Hinge Health Inc’s market cap currently stands at around $3.48 billion, with investors looking forward to this quarter’s earnings report slated for in August.
HNGE’s current price about 8.63% and 9.48% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.23, while 7-day volatility ratio is 9.73% and 7.90% in the 30-day chart. Further, Hinge Health Inc (HNGE) has a beta value of 0. Analysts have given the company’s stock an average 52-week price target of $45, forecast between a low of $41 and high of $48. Looking at the price targets, the low is 8.09% off current price level while to achieve the yearly target high, price needs to move -7.6%. Nonetheless, investors will most likely welcome a -0.87% jump to $45 which is the analysts’ median price.
If we refocus on Hinge Health Inc (NYSE:HNGE), historical trading data shows that trading volumes averaged 1.39 million over the past 3 months. The company’s latest data on shares outstanding shows there are 78.02 million shares.
The 25.80% of Hinge Health Inc’s shares are in the hands of company insiders while institutional holders own 11.20% of the company’s shares. It is this reason that could see investor optimism for the HNGE stock continues to rise going into the next quarter.
